期刊文献+

自噬通过p38/c-Jun信号通路促进乳腺癌细胞对他莫昔芬耐药的研究 被引量:1

Autophagy facilitates breast cancer cells to resist tamoxifen by p38/c-Jun pathway
下载PDF
导出
摘要 目的 探讨自噬在乳腺癌细胞中对他莫昔芬耐药的影响。方法 免疫荧光法计数MCF-7及MCF-7/TAMR中含有自噬体的细胞比例及平均每个细胞中自噬体的个数;蛋白印迹法检测MCF-7和MCF-7/TAMR中p38、c-Jun和LC3表达的差异;逐步法检测当LC3的表达改变时,产生耐药细胞株时间的差异。结果 与MCF-7比较,MCF-7/TAMR中含有自噬体的细胞比例及平均每个细胞中自噬体的个数均明显增多;MCF-7/TAMR中LC3蛋白的表达水平明显增高;在诱导TAM耐药过程中LC3的表达水平与耐药细胞株的产生时间呈负相关。在MCF-7/TAMR中磷酸化的p38和c-Jun表达明显增加。结论 自噬促进乳腺癌细胞对他莫昔芬耐药,通过降低自噬相关蛋白的表达活性能够抑制乳腺癌耐药细胞的产生,这可能成为难治性乳腺癌治疗的新途径。 Objective To investigate the effects of autophagy on breast cancer cells to tamoxifen resistance.Methods Immunofluorescence was used to count the proportion of the cells with autophagy in MCF-7 and MCF-7/TAMR,as well as,the average of autophagosome in each cells.Western blotting was used to detect the different expressions of p38,c-jun and LC3 in MCF-7 and MCF-7/TAMR.Stepwise selection was used to detect the duration of resistance to different doses of tamoxifen when upregulating or downregulating of LC3.Western blot was facilitated to investigate changes of activity of p38/c-jun.Rusults Compared with MCF-7,the proportion of the cells with autophagosome in MCF-7/TAMR was markedly increased,the same as the average of autophagosome in each cells.Compared with MCF-7,LC3,especially LC3IIprotein expressive levels in MCF-7 / TAMR was significantly increased.The expressive level of LC3 during the induction process of TAM resistance was negative correlated with resistant cell lines.The expressions of phosphorylated p38 and c-Jun in MCF-7/TAMR were significantly increased.Conclusion Autophagy promotes breast cancer cells to resistant to tamoxifen,due to downregulation of the expression of autophagy related proteins which may inhibit the generation of resistant breast cancer cells.This may be a viable treatment strategy for refractory breast cancer.
出处 《实用肿瘤学杂志》 CAS 2015年第1期22-28,共7页 Practical Oncology Journal
基金 黑龙江省留学基金(LC2009C14)
关键词 自噬 他莫昔芬 LC3 P38 c—Jun Autophagy Tamoxifen LC3 p38 c - Jun
  • 相关文献

参考文献31

  • 1Ricci MS, Zong WX. Chemotherapeutic approaches for targe?ting cell death pathways[J] . Oncologist, 2006 , 11 ( 4) : 342 -357.
  • 2Chen S, Rehman SK, Zhang W, et al. Autophagy is a thera?peutic target in anticancer drug resistance[J] . Biochim Bio?phys Acta,2010,1806(2) :220 -229.
  • 3Chen S, Li X, Feng J, et al. Autophagy facilitates the Lapa?tinib resistance of HER2 positive breast cancer cells[J] . Med Hypotheses,2011 ,77(2) :206 -208.
  • 4Dragowska WH, Weppler SA, Wang JC, et al. Induction of autophagy is an early response to gefitinib and a potential therapeutic target in breast cancer[J]. PLoS One, 2013 , 8 (10) :e76503.
  • 5Sun WL, Chen J , Wang YP, et al. Autophagy protects breast cancer cells from epirubicin - induced apoptosis and facili?tates epirubicin - resistance development[J]. Autophagy, 2011 ,7(9) :1035 -1044.
  • 6Samaddar JS, Gaddy VT, Duplantier J , et al. A role for mac?roautophagy in protection against 4 - hydroxytamoxifen - in?duced cell death and the development of antiestrogen resist?ance[J]. Mol Cancer Ther , 2008 ,7 ( 9) : 2977 - 2987.
  • 7Cook KL, Warri A, Soto - Pantoja DR, et al. Hydroxychloro?quine inhibits autophagy to potentiate antiestrogen respon?siveness in ER + breast cancer[J]. Clin Cancer Res ,2014, 20(12) :3222 -3232.
  • 8Berardi DE, Campodonico PB, Diaz Bessone MI, et al. Auto?phagy : friend or foe in breast cancer development, progres?sion, and treatment[J]. Int J Breast Cancer, 2011 , 2011 : 595092.
  • 9Jordan VC, 0' Malley BW. Selective estrogen - receptor modulators and antihormonal resistance in breast cancer[J]. J Clin Oncol ,2007,25 (36) :5815 - 5824.
  • 10Normanno N , Di Maio M, De Maio E, et al. Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer[J]. Endocr Relat Cancer ,2005,12 (4) : 721 -747.

同被引文献24

引证文献1

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部